---

---

entities : Biontech se    symbols : SNY   

save search

---

Global mRNA-based Vaccines and Therapeutics Market is Projected to Grow Immensely During the Study Period (2019-2032) | DelveInsight
Published: 2024-01-25 (Crawled : 23:00) - prnewswire.com
MTLHY | $29.93 -11.69% 1.1K |

n/a

| -2.09% | O: -1.11% H: 0.1% C: 0.1%
SNYNF | News | $92.7 600K |

Health Technology

| -6.6% | O: 1.8% H: 0.0% C: -1.82%
VRTX | $399.92 1.43% 1.43% 200 |

Health Technology

| -7.53% | O: 0.25% H: 0.27% C: -0.2%
SLN | $22.5 -0.62% -0.22% 0 |

Health Technology

| 18.42% | O: 4.32% H: 0.0% C: -3.68%
SNY | News | $47.36 0.45% 120K |

Health Technology

| -7.26% | O: 0.5% H: 0.0% C: 0.0%
MRNA | News S | $107.15 2.58% 310K |

Health Technology

| 1.6% | O: 0.72% H: 0.34% C: -1.68%
MRUS | $40.45 1.61% 1.55% 0 |

Health Technology

| 18.62% | O: 0.35% H: 2.81% C: -0.53%
ICLR | News | $297.93 3.37% 3.33% 0 |

Health Technology

| 12.22% | O: 1.13% H: 0.82% C: -0.74%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -9.17% | O: -1.35% H: 0.12% C: -0.83%
global therapeutics study market

---

BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer
Published: 2023-12-21 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -3.34% | O: -0.1% H: 0.0% C: 0.0%
SNY | News | $47.36 0.45% 120K |

Health Technology

| -5.12% | O: -0.08% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -14.39% | O: 0.67% H: 1.46% C: 0.08%
bnt323 fda candidate cancer designation therapy

---

BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
Published: 2023-12-18 (Crawled : 18:00) - globenewswire.com
SNY | News | $47.36 0.45% 120K |

Health Technology

| -4.49% | O: 0.45% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -15.02% | O: 0.9% H: 2.47% C: 2.11%
vaccine milestone

---

BioNTech to Inaugurate First African Site on December 18, 2023
Published: 2023-12-12 (Crawled : 12:00) - globenewswire.com
SNY | News | $47.36 0.45% 120K |

Health Technology

| -1.97% | O: 0.43% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -12.42% | O: -0.26% H: 0.6% C: -1.58%
first

---

BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
Published: 2023-11-06 (Crawled : 12:00) - globenewswire.com
GNMSF | News | $289.67 5.3K |

Health Technology

| 0.65% | O: 0.24% H: 3.29% C: -1.11%
SNYNF | News | $92.7 600K |

Health Technology

| 2.04% | O: 0.16% H: 0.0% C: 0.0%
PFE | News A | $26.375 0.44% 1.9M |

Health Technology

| -15.99% | O: 0.19% H: 0.29% C: -0.45%
SNY | News | $47.36 0.45% 120K |

Health Technology

| 1.52% | O: 0.21% H: 0.0% C: 0.0%
GMAB | News | $28.97 9.3K |

Health Technology

| -0.41% | O: 0.55% H: 0.44% C: -1.37%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -8.11% | O: 5.74% H: 3.18% C: -1.55%
update financial results

---

Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Published: 2023-10-26 (Crawled : 11:00) - globenewswire.com
PFE | News A | $26.375 0.44% 1.9M |

Health Technology

| -14.55% | O: -0.39% H: 2.48% C: 1.8%
SNY | News | $47.36 0.45% 120K |

Health Technology

| -12.84% | O: 0.09% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -7.6% | O: 0.99% H: 1.81% C: 0.47%
covid-19 vaccine positive influenza topline program

---

BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
Published: 2023-10-23 (Crawled : 15:30) - globenewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -10.22% | O: 0.73% H: 0.0% C: -0.48%
SNY | News | $47.36 0.45% 120K |

Health Technology

| -11.6% | O: -0.69% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -3.19% | O: -2.24% H: 7.12% C: 4.11%
bnt211 candidate congress tumors positive update cell car-t therapy

---

BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023
Published: 2023-10-23 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -10.22% | O: 0.73% H: 0.0% C: -0.48%
SNY | News | $47.36 0.45% 120K |

Health Technology

| -11.6% | O: -0.69% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -3.19% | O: -2.24% H: 7.12% C: 4.11%
day report innovation update series financial results

---

BioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial with mRNA-based Individualized Neoantigen Specific Immunotherapy in New Cancer Indication
Published: 2023-10-19 (Crawled : 11:00) - globenewswire.com
SNY | News | $47.36 0.45% 120K |

Health Technology

| -13.89% | O: -2.42% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -6.75% | O: -0.4% H: 0.4% C: -0.81%
cancer immunotherapy trial

---

BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
Published: 2023-10-16 (Crawled : 08:00) - globenewswire.com
SNY | News | $47.36 0.45% 120K |

Health Technology

| -15.51% | O: -0.26% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -15.03% | O: -5.24% H: 1.85% C: -1.2%
congress program

---

Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
Published: 2023-10-16 (Crawled : 07:00) - globenewswire.com
SNY | News | $47.36 0.45% 120K |

Health Technology

| -15.51% | O: -0.26% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -15.03% | O: -5.24% H: 1.85% C: -1.2%
update

---

Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
Published: 2023-09-28 (Crawled : 17:00) - globenewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -14.17% | O: -2.28% H: 0.0% C: -0.06%
SNY | News | $47.36 0.45% 120K |

Health Technology

| -14.23% | O: -1.61% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -14.65% | O: 0.21% H: 0.04% C: -1.27%
covid-19 vaccine health authorization canada

---

Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte
Published: 2023-09-18 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -15.73% | O: -0.62% H: 0.0% C: -1.16%
LLY | News | $735.9 0.63% 180K |

Health Technology

| 28.02% | O: 0.06% H: 1.19% C: 0.58%
SNY | News | $47.36 0.45% 120K |

Health Technology

| -14.76% | O: -0.09% H: 1.16% C: 1.16%
MRUS | $40.45 1.61% 1.55% 0 |

Health Technology

| 62.58% | O: -0.16% H: 2.46% C: 0.56%
KURA | News | $18.48 1.59% 13K |

Health Technology

| 89.68% | O: -0.1% H: 2.4% C: 0.52%
IOVA M | $11.52 1.77% 160K |

Health Technology

| 90.89% | O: -0.51% H: 1.5% C: -7.97%
INCY | $51.98 0.12% 72K |

Health Technology

| -12.75% | O: 0.03% H: 2.18% C: 1.8%
FUSN | $21.415 0.45% 110K |

Health Technology

| 704.53% | O: 0.0% H: 0.41% C: -2.26%
CALT | $18.0825 56 |

Health Technology

| 4.69% | O: -6.2% H: 4.2% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -19.29% | O: -0.01% H: 1.99% C: 1.28%
companies cell growth market

---

BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
Published: 2023-09-18 (Crawled : 11:00) - globenewswire.com
SNY | News | $47.36 0.45% 120K |

Health Technology

| -15.86% | O: -1.29% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -22.16% | O: 0.0% H: 0.16% C: -3.56%
partnership vaccine mrna 100

---

RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published: 2023-09-15 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 600K |

Health Technology

| -14.44% | O: 1.53% H: 0.0% C: 0.0%
NVSEF | News | $95.11 5.4% 0 |

Health Technology

| 12.22% | O: 0.79% H: 0.0% C: 0.0%
ALPMY | News | $9.53 690K |

Manufacturing

| -36.42% | O: 3.0% H: 0.0% C: -3.43%
PFE | News A | $26.375 0.44% 1.9M |

Health Technology

| -23.1% | O: -0.26% H: 1.04% C: 0.03%
NVS | News | $98.17 3.21% 780K |

Health Technology

| -6.93% | O: 1.51% H: 0.26% C: -0.72%
SRPT | $119.15 1.87% 25K |

Health Technology

| -2.31% | O: -0.27% H: 0.54% C: -0.84%
SNY | News | $47.36 0.45% 120K |

Health Technology

| -15.17% | O: 0.82% H: 0.0% C: 0.0%
MRNA | News S | $107.15 2.58% 310K |

Health Technology

| -7.4% | O: 0.16% H: 2.0% C: 1.42%
IONS | $41.07 2.6K |

Health Technology

| -5.89% | O: -0.57% H: 0.35% C: -1.11%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -22.67% | O: 0.17% H: 0.48% C: -0.82%
ARWR | $24.115 0.82% 19K |

Health Technology

| -21.68% | O: 0.16% H: 0.46% C: -5.46%
ALNY | $147.93 1.47% 13K |

Health Technology

| -24.48% | O: -0.74% H: 2.42% C: -3.47%
therapeutics market

---

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
Published: 2023-09-11 (Crawled : 20:00) - biospace.com/
PFE | News A | $26.375 0.44% 1.9M |

Health Technology

| -23.33% | O: -0.03% H: 0.18% C: -0.88%
SNY | News | $47.36 0.45% 120K |

Health Technology

| -13.46% | O: 1.65% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -26.74% | O: -0.49% H: 0.2% C: -1.33%
covid-19 fda vaccine approval

---

Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period (2023-2032), Examines DelveInsight | Key Companies to Watch - Roche, AbbVie, AstraZeneca, BeiGene, GlaxoSmithKline, Genentech, Eli Lilly, Novartis
Published: 2023-09-06 (Crawled : 21:00) - prnewswire.com
LLY | News | $735.9 0.63% 180K |

Health Technology

| 30.61% | O: 0.76% H: 2.15% C: 1.6%
RCUS 4 | $14.875 1.33% 6K |

Health Technology

| -34.76% | O: -0.49% H: 0.0% C: -4.96%
SNY | News | $47.36 0.45% 120K |

Health Technology

| -12.16% | O: 1.03% H: 0.0% C: 0.0%
IOVA M | $11.52 1.77% 160K |

Health Technology

| 88.98% | O: -1.5% H: 0.83% C: -1.69%
IMMP | $2.43 4.74% 5.4K |

Health Technology

| 22.75% | O: 0.53% H: 0.53% C: 0.53%
GTHX | $4.28 4.39% 63K |

Health Technology

| 145.51% | O: -0.6% H: 1.2% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -26.69% | O: -1.16% H: 1.14% C: 0.89%
companies breast cancer novartis market

---

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
Published: 2023-08-30 (Crawled : 14:00) - globenewswire.com
SNY | News | $47.36 0.45% 120K |

Health Technology

| -14.3% | O: 0.66% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -28.19% | O: 0.05% H: 0.0% C: 0.0%
covid-19 chmp vaccine positive

---

BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
Published: 2023-08-14 (Crawled : 11:00) - globenewswire.com
SNY | News | $47.36 0.45% 120K |

Health Technology

| -12.71% | O: 0.04% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -16.47% | O: 1.38% H: 0.92% C: 0.59%
management

---

DualityBio Expands Global Strategic Partnership with BioNTech to Accelerate Development of a Third Antibody-Drug Conjugate Therapeutics for Solid Tumors
Published: 2023-08-07 (Crawled : 10:00) - prnewswire.com
SNY | News | $47.36 0.45% 120K |

Health Technology

| -9.95% | O: 0.51% H: 0.0% C: 0.0%
BNTX | News | $88.19 0.21% 13K |

Health Technology

| -17.35% | O: -5.14% H: 0.35% C: -2.48%
partnership tumors global therapeutics

---

Gainers vs Losers

76%

24%

Top 10 Gainers

MTTR | News M | $4.625 165.81% 5.5M |

AGBA | $2.615 109.2% 14M |

Finance

EDBL | News | $7.37 96.01% 650K |

PALI | $7.64 54.97% 14M |

Manufacturing

OPRT | News | $3.19 41.78% 3M |

Finance

PEGY | $0.0629 37.34% 110M |

Manufacturing

MLEC | $1.87 33.57% 1.6M |

n/a

ATGL | $3.66 27.97% 150K |

SMFL | $5.35 22.99% 11M |

Manufacturing

KULR | $0.5446 22.0% 6.8M |

Manufacturing

---

Your saved searches

---